Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
Gross margin
€ 1 million
▲ 13% vs 2024
Profit
Growing€ 354,875
▲ 28% vs 2024
Debts
Normal€ 650,408
▲ 23% vs 2024
MBM PHARMA from Oudergem, company number BE0454016517, closed financial year 2025 with a result of € 354,875 after tax. For that financial year MBM PHARMA recorded a gross margin of € 1 million and equity of € 221,840. Compared with financial year 2024, the result moved from € 277,451 to € 354,875. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.
What happened at MBM PHARMA?
What happened at MBM PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 354,875 (▲ 28% vs 2024). Source: NBB ↗
- VV FINANCE SRL became a director. NBB
- New establishment in Namur. KBO
- MBM GROUPE SPRL became a director. NBB
- New establishment in Oudergem. KBO
- THIERRY GRAULICH became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 264,532 profit in 2022 to € 354,875 profit in 2025.
Paid € 278,577 in corporate taxes since 2022.
Best year ever: 2025, with € 354,875 profit.
On average € 104,500 of value added per employee in 2025.
A new publication or filing at MBM PHARMA? We notify you, reason included.
Follow MBM PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind MBM PHARMA are THIERRY GRAULICH, VV FINANCE SRL and MBM GROUPE SPRL. The same people are also behind MBM Groupe, KUNZEA, MBM Medical, MASTERED BUSINESS MANAGEMENT & EDITION and MBM Cogeval.
Directors
According to the 2025 annual accounts
since 2000
Director · represented by Jean-Philippe WYDOCK
Also active at: MBM Groupe, MBM Medical, MBM Cogeval
since 2024
Director · represented by CHRISTOPHE DEREUME
Also active at: MBM Medical, MBM Cogeval
since 2013
Establishments
Establishment units
Physical locations of this company
Tedescolaan 7
1160 Oudergem
Tedescolaan 7 box 4
1160 Oudergem
Active since 1 January 2008
Chaussée de Liège(JB) 624
5100 Namur
Active since 3 December 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
BV GROUP
€ 36,957 gross margin · 2025
BECOVA
€ -10,483 gross margin · 2025
Xirius Public
€ 131,503 gross margin · 2024
AMAND & CO
€ 34,452 gross margin · 2025
REVUE ADMINISTRATION PUBLIQUE
+21 more
Details
- Company number
- 0454.016.517
- VAT number
- BE 0454.016.517
- Registered office
- Tedescolaan 7, 1160 Oudergem
- Names & denominations
- MBM PHARMA · M.B.M.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 1994
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Boekhouders
Activiteiten van (gecertificeerde) (fiscaal) accountants
Boekhouders en boekhouders-fiscalisten
Belastingconsulenten
Accountants en belastingconsulenten